142 related articles for article (PubMed ID: 23720071)
1. Active surveillance, radiofrequency ablation, or cryoablation for the nonsurgical management of a small renal mass: a cost-utility analysis.
Bhan SN; Pautler SE; Shayegan B; Voss MD; Goeree RA; You JJ
Ann Surg Oncol; 2013 Oct; 20(11):3675-84. PubMed ID: 23720071
[TBL] [Abstract][Full Text] [Related]
2. Metastatic colorectal carcinoma: cost-effectiveness of percutaneous radiofrequency ablation versus that of hepatic resection.
Gazelle GS; McMahon PM; Beinfeld MT; Halpern EF; Weinstein MC
Radiology; 2004 Dec; 233(3):729-39. PubMed ID: 15564408
[TBL] [Abstract][Full Text] [Related]
3. The cost-effectiveness of immediate treatment, percutaneous biopsy and active surveillance for the diagnosis of the small solid renal mass: evidence from a Markov model.
Heilbrun ME; Yu J; Smith KJ; Dechet CB; Zagoria RJ; Roberts MS
J Urol; 2012 Jan; 187(1):39-43. PubMed ID: 22088331
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of hepatic resection versus percutaneous radiofrequency ablation for early hepatocellular carcinoma.
Cucchetti A; Piscaglia F; Cescon M; Colecchia A; Ercolani G; Bolondi L; Pinna AD
J Hepatol; 2013 Aug; 59(2):300-7. PubMed ID: 23603669
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness analysis of stereotactic body radiotherapy and radiofrequency ablation for medically inoperable, early-stage non-small cell lung cancer.
Sher DJ; Wee JO; Punglia RS
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):e767-74. PubMed ID: 21300476
[TBL] [Abstract][Full Text] [Related]
6. Radiofrequency ablation versus nephron-sparing surgery for small unilateral renal cell carcinoma: cost-effectiveness analysis.
Pandharipande PV; Gervais DA; Mueller PR; Hur C; Gazelle GS
Radiology; 2008 Jul; 248(1):169-78. PubMed ID: 18458248
[TBL] [Abstract][Full Text] [Related]
7. Long-term oncological and overall outcomes of percutaneous radio frequency ablation in high risk surgical patients with a solitary small renal mass.
Levinson AW; Su LM; Agarwal D; Sroka M; Jarrett TW; Kavoussi LR; Solomon SB
J Urol; 2008 Aug; 180(2):499-504; discussion 504. PubMed ID: 18550123
[TBL] [Abstract][Full Text] [Related]
8. Early experience with the cryoablation balloon procedure for the treatment of atrial fibrillation by an experienced radiofrequency catheter ablation center.
Mandell J; Amico F; Parekh S; Snow J; Germano J; Cohen TJ
J Invasive Cardiol; 2013 Jun; 25(6):288-92. PubMed ID: 23735354
[TBL] [Abstract][Full Text] [Related]
9. Long-term oncologic outcomes after radiofrequency ablation for T1 renal cell carcinoma.
Psutka SP; Feldman AS; McDougal WS; McGovern FJ; Mueller P; Gervais DA
Eur Urol; 2013 Mar; 63(3):486-92. PubMed ID: 22959191
[TBL] [Abstract][Full Text] [Related]
10. Percutaneous cryoablation of solitary sporadic renal cell carcinomas.
Schmit GD; Thompson RH; Kurup AN; Weisbrod AJ; Carter RE; Callstrom MR; Atwell TD
BJU Int; 2012 Dec; 110(11 Pt B):E526-31. PubMed ID: 22584010
[TBL] [Abstract][Full Text] [Related]
11. Hepatocellular adenoma: cost-effectiveness of different treatment strategies.
van der Sluis FJ; Bosch JL; Terkivatan T; de Man RA; Ijzermans JN; Hunink MG
Radiology; 2009 Sep; 252(3):737-46. PubMed ID: 19717753
[TBL] [Abstract][Full Text] [Related]
12. An economic analysis of endoscopic ablative therapy for management of nondysplastic Barrett's esophagus.
Das A; Wells C; Kim HJ; Fleischer DE; Crowell MD; Sharma VK
Endoscopy; 2009 May; 41(5):400-8. PubMed ID: 19418393
[TBL] [Abstract][Full Text] [Related]
13. Transcatheter aortic valve replacement in nonsurgical candidates with severe, symptomatic aortic stenosis: a cost-effectiveness analysis.
Simons CT; Cipriano LE; Shah RU; Garber AM; Owens DK; Hlatky MA
Circ Cardiovasc Qual Outcomes; 2013 Jul; 6(4):419-28. PubMed ID: 23838104
[TBL] [Abstract][Full Text] [Related]
14. Percutaneous ablation of renal masses measuring 3.0 cm and smaller: comparative local control and complications after radiofrequency ablation and cryoablation.
Atwell TD; Schmit GD; Boorjian SA; Mandrekar J; Kurup AN; Weisbrod AJ; Chow GK; Leibovich BC; Callstrom MR; Patterson DE; Lohse CM; Thompson RH
AJR Am J Roentgenol; 2013 Feb; 200(2):461-6. PubMed ID: 23345372
[TBL] [Abstract][Full Text] [Related]
15. Cost-utility analysis of preoperative radiotherapy in patients with rectal cancer undergoing total mesorectal excision: a study of the Dutch Colorectal Cancer Group.
Van Den Brink M; Van Den Hout WB; Stiggelbout AM; Klein Kranenbarg E; Marijnen CA; Van De Velde CJ; Kievit J;
J Clin Oncol; 2004 Jan; 22(2):244-53. PubMed ID: 14665610
[TBL] [Abstract][Full Text] [Related]
16. Economic evaluation of everolimus versus sorafenib for the treatment of metastatic renal cell carcinoma after failure of first-line sunitinib.
Casciano R; Chulikavit M; Di Lorenzo G; Liu Z; Baladi JF; Wang X; Robertson J; Garrison L
Value Health; 2011; 14(6):846-51. PubMed ID: 21914504
[TBL] [Abstract][Full Text] [Related]
17. Cost Effectiveness of External Beam Radiation Therapy versus Percutaneous Image-Guided Cryoablation for Palliation of Uncomplicated Bone Metastases.
Chang EM; Shaverdian N; Capiro N; Steinberg ML; Raldow AC
J Vasc Interv Radiol; 2020 Aug; 31(8):1221-1232. PubMed ID: 32674872
[TBL] [Abstract][Full Text] [Related]
18. [Active surveillance for renal cell carcinoma].
Doehn C; Witzsch U; Siebels M
Aktuelle Urol; 2012 Jul; 43(4):243-9. PubMed ID: 22869494
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness analysis of nephron sparing options for the management of small renal masses.
Chang SL; Cipriano LE; Harshman LC; Garber AM; Chung BI
J Urol; 2011 May; 185(5):1591-7. PubMed ID: 21419445
[TBL] [Abstract][Full Text] [Related]
20. Excise, ablate or observe: the small renal mass dilemma--a meta-analysis and review.
Kunkle DA; Egleston BL; Uzzo RG
J Urol; 2008 Apr; 179(4):1227-33; discussion 1233-4. PubMed ID: 18280512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
